Suppr超能文献

基于流感 H9N2 病毒保守基质蛋白 M1 及其表位筛选的 DNA 初免-亚单位蛋白加强免疫策略。

Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening.

机构信息

Shanghai Institute of Biological Products, Shanghai, 200052, China.

Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, China.

出版信息

Sci Rep. 2020 Mar 5;10(1):4144. doi: 10.1038/s41598-020-60783-z.

Abstract

Developing an effective universal influenza vaccine against influenza virus with highly conserved antigenic epitopes could induce a broad-spectrum immune response to prevent infection. The soluble protein M1 that can induce the M1 specific immune response was first confirmed in our previous study. In this study, we characterized the immune response induced by DNA prime-subunit protein boost strategy based on the relatively conserved matrix protein 1 (M1) in the BALB/c mouse model, and evaluated its protection ability against a lethal challenge of homologous H9N2 avian influenza virus (A/Chicken/Jiangsu/11/2002). The results showed that 100 μg DNA prime + 100 μg M1 subunit protein boost-strategy significantly increased antibody levels more than vaccination with M1 DNA or M1 subunit protein alone, and induced a more balanced Th1 / Th2 immune response, which not only can provide protection against the homologous virus but also can provide part of the cross-protection against the heterosubtypic PR8 H1N1 strain. In addition, we used an Elispot assay to preliminary screen the T cell epitope in M1 protein, and identified that p22 (M1 VLSIIPSGPLKAEIA) epitope was the only immunodominant M1-specific CD4 T cell epitopes, which could be helpful in understanding the function of influenza virus T cell epitopes.

摘要

开发针对具有高度保守抗原表位的流感病毒的有效通用流感疫苗可以诱导广谱免疫反应以预防感染。我们之前的研究首次证实了可溶性蛋白 M1 可以诱导 M1 特异性免疫反应。在这项研究中,我们在 BALB/c 小鼠模型中基于相对保守的基质蛋白 1(M1)表征了基于 DNA 初级-亚单位蛋白加强策略诱导的免疫反应,并评估了其对同源 H9N2 禽流感病毒(A/鸡/江苏/11/2002)致死性挑战的保护能力。结果表明,100μg DNA 初级+100μg M1 亚单位蛋白加强策略比单独接种 M1 DNA 或 M1 亚单位蛋白显著增加了抗体水平,并且诱导了更平衡的 Th1/Th2 免疫反应,不仅可以提供针对同源病毒的保护,还可以提供针对异源 PR8 H1N1 株的部分交叉保护。此外,我们使用 Elispot 分析初步筛选了 M1 蛋白中的 T 细胞表位,并鉴定出 p22(M1 VLSIIPSGPLKAEIA)表位是唯一的免疫优势 M1 特异性 CD4 T 细胞表位,这有助于理解流感病毒 T 细胞表位的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5af2/7057951/4ecfbfc67fd5/41598_2020_60783_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验